Managers / Q2 2023 · view latest →
Sonic GP LLC
CIK 0001964290 · 400 HOBRON LANE, SUITE 3709, HONOLULU, HI, 96815 · 8086493381
Summary
Sonic GP LLC reported $150M in U.S.-listed holdings across 24 positions for Q2 2023.
Its largest position, FENC, represents 14.2% of the portfolio.
Compared with Q1 2023, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 76.7% · $115M
- Other · 17.2% · $26M
- MLP · 3.5% · $5M
- ADR · 2.4% · $4M
- Equity WRT · 0.2% · $338,794
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MANCHESTER UTD PLC NEW | NEW | +750.0K | 750.0K | +$18M | $18M |
| RGNXREGENXBIO INC | ADDED | +550.0K | 743.1K | +$11M | $15M |
| USFDUS FOODS HLDG CORP | SOLD OUT | −200.0K | 0 | −$7M | $0 |
| RDNRADIAN GROUP INC | SOLD OUT | −300.0K | 0 | −$7M | $0 |
| SPNTSIRIUSPOINT LTD | ADDED | +100.0K | 502.2K | +$1M | $5M |
| UALUNITED AIRLS HLDGS INC | HELD | +0 | 171.8K | +$2M | $9M |
| ADVERUM BIOTECHNOLOGIES INC | HELD | +0 | 2.00M | +$2M | $3M |
| FENCFENNEC PHARMACEUTICALS INC | HELD | +0 | 2.41M | +$1M | $21M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $45M | 15 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $44M | 15 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $48M | 15 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $76M | 15 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $87M | 16 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $103M | 23 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $150M | 24 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $131M | 25 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $133M | 25 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.